FHTX Stock Analysis: Buy, Sell, or Hold?
FHTX - Foghorn Therapeutics Inc. Common Stock
$6.64
0.05 (0.76%)
▲
5d:
+36.07%
30d:
+23.42%
90d:
+56.6%
WAIT
LOW Confidence
Analysis Updated: Aug 12, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When FHTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: FHTX is 11.0% above its trading range ($5.98). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: FHTX is 11.0% above its trading range ($5.98). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: FHTX is currently trading at $6.64, which is considered extended relative to its 30-day fair value range of $4.81 to $5.98.
Technical Outlook: Technically, FHTX is in a uptrend. Immediate support is located at $4.41, while resistance sits at $6.85.
Market Sentiment: FHTX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.44 (+73.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FHTX is in a uptrend. Immediate support is located at $4.41, while resistance sits at $6.85.
Market Sentiment: FHTX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.44 (+73.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.81 -
$5.98
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
15.8%
All Signals
- BEARISH: Price significantly overextended (+11.0% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 73.7% below Wall St target ($11.44)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.81 -
$5.98
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.41
Resistance Level
$6.85
Current Trend
Uptrend
Technical data as of
Aug 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.67
Wall Street Target
$11.44
(+73.7%)
Revenue Growth (YoY)
112.7%
Profit Margin
-175.8%
Share & Embed Analysis
Last updated: August 12, 2026 4:33 PM ET
Data refreshes hourly during market hours. Next update: 5:33 PM
Data refreshes hourly during market hours. Next update: 5:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FHTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 53 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 57 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 30 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 52 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$140 | 59 HOLD |
